levocetirizine dihydrochloride
NDC 43598-735, levocetirizine dihydrochloride, tablet, coated, from Dr. Reddy's Laboratories Inc..
- Product NDC
- 43598-735
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA210375
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43598-735 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE5 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43598-735-04 | 43598073504 | 1 BOTTLE in 1 CARTON (43598-735-04) / 120 TABLET, COATED in 1 BOTTLE |
| 43598-735-22 | 43598073522 | 1 BOTTLE in 1 CARTON (43598-735-22) / 55 TABLET, COATED in 1 BOTTLE |
| 43598-735-30 | 43598073530 | 1 BOTTLE in 1 CARTON (43598-735-30) / 30 TABLET, COATED in 1 BOTTLE |
| 43598-735-35 | 43598073535 | 1 BOTTLE in 1 CARTON (43598-735-35) / 35 TABLET, COATED in 1 BOTTLE |
| 43598-735-58 | 43598073558 | 1 BOTTLE in 1 CARTON (43598-735-58) / 10 TABLET, COATED in 1 BOTTLE |
| 43598-735-79 | 43598073579 | 2 BLISTER PACK in 1 CARTON (43598-735-79) / 5 TABLET, COATED in 1 BLISTER PACK |
| 43598-735-80 | 43598073580 | 1 BOTTLE in 1 CARTON (43598-735-80) / 80 TABLET, COATED in 1 BOTTLE |
| 43598-735-90 | 43598073590 | 1 BOTTLE in 1 CARTON (43598-735-90) / 90 TABLET, COATED in 1 BOTTLE |
| 43598-735-95 | 43598073595 | 2 BOTTLE in 1 CARTON (43598-735-95) / 200 TABLET, COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43598-735 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43598-735 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43598-735. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.